This $170,101 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) supports research by Brigham & Women's Hospital to characterize the spatial heterogeneity of synovial inflammation in rheumatoid arthritis. The project aims to use advanced statistical techniques and artificial intelligence to identify the spatial building blocks of synovial inflammation and relate them to disease heterogeneity across rheumatoid arthritis. This work will enhance the awardee's expertise in immunology, spatial analysis methods, and scientific leadership, positioning them to become an R01-funded investigator using these approaches to improve understanding of rheumatoid arthritis. The award runs from January 1, 2025 through December 31, 2029 and is being carried out at Brigham & Women's Hospital, a subsidiary of the larger Partners Healthcare System organization.
Generated 3/4/25, 2:04 AM